Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Mixed connective tissue disease secondary prevention
Introduction
Overview
Overview
In MCTD effective measures for the secondary prevention of Raynaud’s disease include vasodilator therapies (such as calcium channel blockers), preventive approaches like avoidance of cold temperatures, smoking, and sympathomimetic agents and use of warm and protection techniques of fingers. Current strategies include Bosentan (endothelin receptor antagonist) as the recommended medication for the prevention of new digital ulcers.
Secondary Prevention
Secondary Prevention
- In MCTD effective measures for the secondary prevention of Raynaud’s disease include:[1]
- Vasodilator therapies (such as calcium channel blockers)
- Preventive approaches like avoidance of cold temperatures, smoking, and sympathomimetic agents
- Use of warm and protection techniques of fingers
- Current strategies include Bosentan (endothelin receptor antagonist) as the recommended medication for the prevention of new digital ulcers.
References
References
- ↑ Ortega-Hernandez OD, Shoenfeld Y (February 2012). “Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment”. Best Pract Res Clin Rheumatol. 26 (1): 61–72. doi:10.1016/j.berh.2012.01.009. PMID 22424193.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]